Clinical trials: sponsored by Xijing Hospital
Ischemic Stroke
Ginsenoside-Rd for Acute Ischemic Stroke
The purpose of this study is to evaluate the efficacy and safety of ginsenoside-Rd for acute ischemic stroke.
- Trial name
- NCT00591084
- Testing
- ginsenoside-Rd 10 mg, ginsenoside-Rd 20mg
- Where
- China
- Volunteers
- 199 people
- Sponsor
- Xijing Hospital
Heart Failure
Assessment of Efficacies of Cardiac Resynchronization Therapies (CRT-P/D) for Heart Failure Patients in China
The ADOPT study is a prospective, nested case-controlled and open label clinical trial. About 40 centers across China participate in this study with a planned 800 Chinese cases enrollment.
- Trial name
- ADOPT (NCT01018667)
- Where
- China
- Volunteers
- 400 people
- Sponsor
- Xijing Hospital
Breast Cancer
Neoadjuvant Endostatin and Chemotherapy for Breast Cancer
This study was designed to determine the efficacy and safety of neoadjuvant docetaxel and epirubicin (DE) with or without human recombinant endostatin (endostar) for breast cancer patients.
- Trial name
- NCT00604435
- Testing
- docetaxel and epirubicin, docetaxel and epirubicin plus endostatin
- Where
- China
- Volunteers
- 69 people
- Sponsor
- Xijing Hospital
Congenital Heart Defects, Heart Valve Diseases
Cardiac Operation Under Totally Endoscope and Cardiopulmonary Bypass (CPB)
Conventional cardiac operations are performed with median sternotomy, which is related to great wound, morbidities, longer duration in hospital and most significantly, cosmetic problems.
- Trial name
- CPB (NCT00921596)
- Testing
- cardiac operation with totally endoscopic method
- Where
- China
- Volunteers
- 800 people
- Sponsor
- Xijing Hospital
General Paresis
Clinical Findings in General Paresis
This is a study of the clinical and neuroimaging of general paresis. The investigators studied six patients with general paresis.
- Trial name
- NCT00921648
- Where
- China
- Volunteers
- 6 people
- Sponsor
- Xijing Hospital
Brain Injury, Myocardial Injury
Preconditioning With Hyperbaric Oxygen in Cardiovascular Surgery
Animal studies have shown that preconditioning with hyperbaric oxygen can induce central nervous system and heart ischemic tolerance.
- Trial name
- NCT00817791
- Testing
- Hyperbaric oxygen pretreatment (GR2200)
- Volunteers
- 49 people
- Sponsor
- Xijing Hospital
Heart Defects, Congenital, Cardiac Surgical Procedures
Myocardial Protection With Adenosine Preconditioning
Adenosine has been proved to be an important mediator of myocardial protection induced by ischemic preconditioning. The hypothesis of this study is that adenosine preconditioning can provide additional myocardial protection in…
- Conditions
- Heart Defects, Congenital, Cardiac Surgical Procedures, Myocardial Reperfusion Injury, Adenosine
- Trial name
- NCT00881686
- Testing
- adenosine
- Where
- China
- Volunteers
- 238 people
- Sponsor
- Xijing Hospital
Trigeminal Neuralgia, Pain
Clinical Trial of Hyperbaric Oxygen Treatment in Trigeminal Neuralgia Patients
The purpose of this study is to determine whether the hyperbaric oxygen treatment reduces pain and improve the life quality in trigeminal neuralgia patients.
- Trial name
- NCT00866424
- Testing
- Hyperbaric oxygen, Mock hyperbaric chamber
- Where
- China
- Volunteers
- 30 people
- Sponsor
- Xijing Hospital
Atrial Fibrillation
Radiofrequency Ablation of Atrial Fibrillation Under Totally Thoracoscope
Atrial fibrillation (AF) is a common supraventricular arrhythmia, the incidence of which increases with age. The aim of treatment of atrial fibrillation is to restore sinus rhythm and return the heart to atrioventricular…
- Trial name
- NCT00844584
- Testing
- epicardial radiofrequency ablation
- Where
- China
- Volunteers
- 20 people
- Sponsor
- Xijing Hospital
Ischemic Stroke
Efficacy and Safety of Ginsenoside-Rd for Acute Ischemic Stroke
The purpose of this phase 3 study is to validate the efficacy and safety of ginsenoside-Rd for acute ischemic stroke.
- Trial name
- NCT00815763
- Testing
- ginsenoside-Rd
- Where
- China
- Volunteers
- 390 people
- Sponsor
- Xijing Hospital
Rheumatic Valve Disease
Clinical Trial of Electro-Acupuncture Preconditioning in Patients Underwent Heart Valve Replacement Surgery
The purpose of this study is to investigate the protective effect of electro-acupuncture preconditioning in patients underwent cardiac surgery.
- Trial name
- NCT00732459
- Testing
- Electro-acupuncture preconditioning
- Where
- China
- Volunteers
- 60 people
- Sponsor
- Xijing Hospital
Coronary Disease
Long Term Efficacy and Safety of Firebird Sirolimus-Eluting Stent In Complex Coronary Lesions
The purpose of this study is to investigate the long term efficacy and safety of firebird sirolimus-eluting stent for treatment of complex coronary Lesions.
- Trial name
- FIREMAN (NCT00552656)
- Testing
- Firebird(TM) Sirolimus-Eluting Stent
- Where
- China
- Volunteers
- 1,000 people
- Sponsor
- Xijing Hospital
Chemotherapy-Induced Nausea and Vomiting
An Efficacy and Safety Study of Palonosetron in Preventing Chemotherapy-Induced Nausea and Vomiting (CINV) in the Chinese Cancer Patients
This clinical study was designed to demonstrate that a single, intravenous dose of palonosetron 0.25 mg was not inferior to granisetron 3 mg in preventing acute and delayed CINV and was also well tolerated in the Chinese cancer…
- Trial name
- NCT00666783
- Testing
- palonosetron, Granisetron
- Where
- China
- Volunteers
- 208 people
- Sponsor
- Xijing Hospital
Pharmaceutical Preparations
Human Partial Facial Allotransplantation
Progress in composite tissue allotransplantation provides a new remedy for severely disfigured patients. We plan to carry out allograft composite tissue transplantation after a careful systemic preparation.
- Trial name
- NCT00663988
- Testing
- human transplantation
- Where
- China
- Volunteers
- 1 people
- Sponsor
- Xijing Hospital
Myocardial Infarction
Long Term Follow-up of Autologous Bone Marrow Mononuclear Cells Therapy in STEMI
The benefit of current reperfusion therapies for ST-elevation myocardial infarction (STEMI) is limited by post-infarction left ventricular (LV) dysfunction.
- Trial name
- NCT00626145
- Testing
- saline infusion, autologous bone marrow mononuclear cells infusion
- Where
- China
- Volunteers
- 37 people
- Sponsor
- Xijing Hospital